Yakira Capital Management’s Phoenix Biotech Acquisition Corp. Unit PBAXU Stock Holding History

Yakira Capital Management’s Portfolio PBAXU Stock Details PBAXU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-100,000	Closed	-$1.07M	–	388
2023 Q1	$1.07M	Hold	100,000	–	–	0.27%	94
2022 Q4	$1.03M	Hold	100,000	–	–	0.21%	121
2022 Q3	$1.01M	Hold	100,000	–	–	0.15%	162
2022 Q2	$1.01M	Hold	100,000	–	–	0.16%	168
2022 Q1	$1.01M	Hold	100,000	–	–	0.14%	185
2021 Q4	$1.01M	Buy	+100,000	New	+$1.01M	0.13%	177

Other funds holding PBAXU

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Yakira Capital Management's PBAXU Position: Q2 2023 in Review

Yakira Capital Management sold out of Phoenix Biotech Acquisition Corp. Unit (PBAXU) in Q2 2023, closing a stake of 100,000 shares — an estimated $1.07M sold.

Yakira Capital Management first reported a position in PBAXU in Q4 2021 and held it in 6 quarters. The position peaked at $1.07M in Q1 2023. 1 fund tracked by Wall St. Rank holds PBAXU as of Q2 2023.

Yakira Capital Management reported no remaining Phoenix Biotech Acquisition Corp. Unit position as of Q2 2023 after selling out during the quarter.
Yakira Capital Management sold 100,000 Phoenix Biotech Acquisition Corp. Unit shares in Q2 2023, an estimated $1.07M.
Yakira Capital Management first reported a position in Phoenix Biotech Acquisition Corp. Unit in Q4 2021 and held it in 6 quarters.
Yakira Capital Management's Phoenix Biotech Acquisition Corp. Unit position peaked at $1.07M in Q1 2023.
1 fund tracked by Wall St. Rank held Phoenix Biotech Acquisition Corp. Unit as of Q2 2023.

Based on Yakira Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.